Neurofibromatosis

18 clinical trials · Condition

Record	Firm	Date
A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I (NCT04461886)	Nobelpharma	2020-07-08
GROWing Up With Rare GENEtic Syndromes (NCT04463316)	dr. Laura C. G. de Graaff-Herder	2018-10-01
Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF (NCT02435628)	Massachusetts General Hospital	2015-02-01
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 (NCT02211768)	National Cancer Institute (NCI)	2014-12-08
Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype (NCT02298270)	Massachusetts General Hospital	2014-03-01
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas (NCT01402817)	Indiana University	2012-03-01
Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas (NCT01140360)	Kent Robertson	2012-02-01
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas (NCT01275586)	Indiana University	2011-01-01
Natural History Study of Patients With Neurofibromatosis Type 2 (NCT00598351)	National Institute of Neurological Disorders and Stroke (NINDS)	2008-03-21
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma (NCT00589784)	Memorial Sloan Kettering Cancer Center	2007-10-01
Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas (NCT01673009)	Indiana University	2006-05-01
Quality of Friendships in Children With Neurofibromatosis (NCT00508235)	M.D. Anderson Cancer Center	2004-12-01
Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 (NCT00754780)	Mayo Clinic	2000-09-01

Track Neurofibromatosis automatically

Every clearance here is in the API, with alerts when new ones post.